CoChat

Effect of continuous allergen challenge on clinical symptoms and mediator release in dust‐mite‐allergic patients

Horak, F., Toth, J., Hirschwehr, R., Marks, B., Stübner, U. P., Jäger, S., Berger, U., Schleinzer, K., Günczler, P. · 1998 · Allergy
Cited by 33

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

This study investigated the early, prolonged immediate, and late‐phase reactions of dust‐mite‐sensitive subjects undergoing long‐term challenge in the Vienna challenge chamber (VCC) in terms of clinical symptoms and inflammatory mediator level patterns in nasal lavage fluids. A concentration of 70 ng Der p 1/m 3 of air (feces of Dermatopliagoides) was maintained over 8 h in the VCC. To show the clinical impact of this challenge model, the effect of a histamine H 1‐receptor antagonist that also has some antiallergic properties (loratadine) was also investigated. The study followed a doubleblind, placebo‐controlled, crossover design. Medication was given orally over 7 days before the provocation at a dose of 10 mg once daily. All 12 patients, whose dust‐mite sensitivity was confirmed by disease history, skin prick test, and RAST, completed the challenge session. The documentation of the chosen parameters was performed every 30 min. Subjective nasal and ocular symptoms were assessed via a visual analog scale of 100 mm. nasal flow was recorded by active anterior rhinomanometry, and mediator release was evaluated with nasal lavages. Clinical aspect: the whole sample population showed a rise of nasal and ocular symptom severity and a nasal flow reduction, which were perceptibly, but not significantly attenuated by active drug treatment. Mediator pattern: in each patient, prostaglandin (PG)D 2 and leukotriene (LT)C 4 levels peaked within the first 2 h of provocation, PGD 2 then moving toward baseline levels, and LTC 4 then again rising continuously. Eosinophil cationic protein (ECP) exhibited a constant level increase over the whole provocation period, and tryptase levels did not change significantly. Whereas the area under the curve values of tryptase and ECP were higher in drug‐treated patients than the placebo group, the early PGD, peak occurring during the first two challenge hours seemed to be mitigated by loratadine. These results reveal that there is no link between the clinical symptoms, the drug efficacy, and the released mediators (LTC 4, PGD 2, ECP and tryptase).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1398-9995.1998.tb03775.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 33

Metadata

Authors
Horak, F., Toth, J., Hirschwehr, R., Marks, B., Stübner, U. P., Jäger, S., Berger, U., Schleinzer, K., & Günczler, P.
Venue
Allergy
Publisher
Wiley
Published
1998-01
Volume
53
Issue
1
Pages
68-72
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W2033460861
Cited by
33
References
1
FWCI
0.44
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of continuous allergen challenge on clinical symptoms and mediator release in dust‐mite‐allergic patients. https://app.cochat.ai/papers/10.1111/j.1398-9995.1998.tb03775.x
The paper
Horak, F., Toth, J., Hirschwehr, R., Marks, B., Stübner, U. P., Jäger, S., Berger, U., Schleinzer, K., & Günczler, P. (1998). Effect of continuous allergen challenge on clinical symptoms and mediator release in dust‐mite‐allergic patients. Allergy. https://doi.org/10.1111/j.1398-9995.1998.tb03775.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.